- Home
- IRON vs CCU Comparison
IRON vs CCU Comparison
Compare IRON & CCU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IRON
- CCU
- Stock Information
- Founded
- IRON 2017
- CCU 1850
- Country
- IRON United States
- CCU Chile
- Employees
- IRON N/A
- CCU N/A
- Industry
- IRON Biotechnology: Pharmaceutical Preparations
- CCU Beverages (Production/Distribution)
- Sector
- IRON Health Care
- CCU Consumer Staples
- Exchange
- IRON Nasdaq
- CCU Nasdaq
- Market Cap
- IRON 2.1B
- CCU 2.2B
- IPO Year
- IRON N/A
- CCU 1992
- Fundamental
- Price
- IRON $67.78
- CCU $11.63
- Analyst Decision
- IRON Strong Buy
- CCU Strong Sell
- Analyst Count
- IRON 10
- CCU 1
- Target Price
- IRON $97.80
- CCU $10.00
- AVG Volume (30 Days)
- IRON 380.9K
- CCU 138.4K
- Earning Date
- IRON 11-11-2025
- CCU 11-05-2025
- Dividend Yield
- IRON N/A
- CCU 2.61%
- EPS Growth
- IRON N/A
- CCU 38.53
- EPS
- IRON N/A
- CCU 0.44
- Revenue
- IRON N/A
- CCU $3,254,866,554.00
- Revenue This Year
- IRON N/A
- CCU $8.27
- Revenue Next Year
- IRON N/A
- CCU $4.37
- P/E Ratio
- IRON N/A
- CCU $13.42
- Revenue Growth
- IRON N/A
- CCU 19.82
- 52 Week Low
- IRON $30.82
- CCU $10.65
- 52 Week High
- IRON $68.79
- CCU $15.75
- Technical
- Relative Strength Index (RSI)
- IRON 69.97
- CCU 41.32
- Support Level
- IRON $65.26
- CCU $11.55
- Resistance Level
- IRON $68.79
- CCU $12.32
- Average True Range (ATR)
- IRON 2.67
- CCU 0.25
- MACD
- IRON 0.53
- CCU -0.01
- Stochastic Oscillator
- IRON 88.97
- CCU 9.74
About IRON Disc Medicine Inc.
Disc Medicine Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for hematologic diseases. It aims to modify fundamental biological pathways associated with the formation and function of red blood cells, specifically heme biosynthesis and iron homeostasis. Its pipeline includes bitopertin for erythropoietic porphyrias (EPs) including erythropoietic protoporphyria (EPP), X-linked protoporphyria (XLP), and Diamond-Blackfan Anemia (DBA); DISC-0974 for the treatment of anemia of myelofibrosis (MF) and anemia of chronic kidney disease (CKD); and DISC-3405 for the treatment of polycythemia vera (PV) and other hematologic disorders. In addition, the Company's preclinical programs include DISC-0998.
About CCU Compania Cervecerias Unidas S.A.
United Breweries Co Inc is a multi-category beverage company with operations in Chile, Argentina, Bolivia, Colombia, Paraguay and Uruguay. The company is a player in each one of the beverage categories in which it participates in Chile, including beer, soft drinks, mineral and bottled water, juice, wine, cider and pisco, among others. The Company has three operating segment with respect to its revenues in the geographic areas of commercial activity: Chile; International business and Wine. It generates maximum revenue from Chile.